ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,455, issued on Feb. 18, was assigned to RELAXERA PHARMAZEUTISCHE GMBH & Co. KG (Bensheim, Germany).
"Medical composition for treating cardiac wasting and cachexia" was invented by Thomas Bernd Dschietzig (Berlin).
According to the abstract* released by the U.S. Patent & Trademark Office: "Human relaxin-2 as active ingredient in a pharmaceutical composition for treating a subject suffering from cachexia syndrome or cardiac wasting or suspected of being at risk of suffering from cardiac wasting or cardiac decompensation is described. Also described are methods of diagnosis of cachexia and cardiac wasting and patients suspected of being at risk of suffering from cardiac decompensati...